

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of immunoglobulin secretion (GO:0051023) | 8.67037383 |
| 2 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 8.58990515 |
| 3 | regulation of regulatory T cell differentiation (GO:0045589) | 8.54734281 |
| 4 | regulation of podosome assembly (GO:0071801) | 8.47230960 |
| 5 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 8.29582052 |
| 6 | positive regulation of B cell mediated immunity (GO:0002714) | 8.29582052 |
| 7 | positive regulation of T cell chemotaxis (GO:0010820) | 8.29331481 |
| 8 | regulation of T cell chemotaxis (GO:0010819) | 8.29331481 |
| 9 | positive regulation of isotype switching (GO:0045830) | 7.69062538 |
| 10 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 6.69911461 |
| 11 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 6.64446340 |
| 12 | positive regulation of DNA recombination (GO:0045911) | 6.60620297 |
| 13 | positive regulation of T cell cytokine production (GO:0002726) | 6.50247229 |
| 14 | regulation of immunoglobulin mediated immune response (GO:0002889) | 6.41698907 |
| 15 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 6.36601564 |
| 16 | regulation of lymphocyte chemotaxis (GO:1901623) | 6.29090565 |
| 17 | positive regulation of immunoglobulin production (GO:0002639) | 6.21137172 |
| 18 | regulation of B cell mediated immunity (GO:0002712) | 6.20830964 |
| 19 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 6.16525510 |
| 20 | regulation of response to tumor cell (GO:0002834) | 5.99650956 |
| 21 | positive regulation of response to tumor cell (GO:0002836) | 5.99650956 |
| 22 | positive regulation of immune response to tumor cell (GO:0002839) | 5.99650956 |
| 23 | regulation of immune response to tumor cell (GO:0002837) | 5.99650956 |
| 24 | positive regulation of humoral immune response (GO:0002922) | 5.99111994 |
| 25 | eosinophil chemotaxis (GO:0048245) | 5.96865789 |
| 26 | activated T cell proliferation (GO:0050798) | 5.86589017 |
| 27 | cellular extravasation (GO:0045123) | 5.74577045 |
| 28 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 5.71390567 |
| 29 | regulation of isotype switching (GO:0045191) | 5.65340759 |
| 30 | regulation of chronic inflammatory response (GO:0002676) | 5.59201200 |
| 31 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 5.55308404 |
| 32 | regulation of immunoglobulin production (GO:0002637) | 5.54777377 |
| 33 | cellular response to ethanol (GO:0071361) | 5.52571759 |
| 34 | myeloid dendritic cell differentiation (GO:0043011) | 5.49755458 |
| 35 | positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531) | 5.34372463 |
| 36 | NIK/NF-kappaB signaling (GO:0038061) | 5.33865043 |
| 37 | eosinophil migration (GO:0072677) | 5.31870422 |
| 38 | negative regulation of T cell mediated immunity (GO:0002710) | 5.30678272 |
| 39 | negative regulation of B cell apoptotic process (GO:0002903) | 5.27204891 |
| 40 | positive regulation of interleukin-17 production (GO:0032740) | 5.21563949 |
| 41 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 5.11395746 |
| 42 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 5.06875640 |
| 43 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.02590091 |
| 44 | positive regulation of activated T cell proliferation (GO:0042104) | 4.96688210 |
| 45 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 4.91200177 |
| 46 | monocyte chemotaxis (GO:0002548) | 4.86208715 |
| 47 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 4.85655052 |
| 48 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 4.85655052 |
| 49 | regulation of mononuclear cell migration (GO:0071675) | 4.79444419 |
| 50 | myeloid dendritic cell activation (GO:0001773) | 4.75592743 |
| 51 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.75136431 |
| 52 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.75136431 |
| 53 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.74599517 |
| 54 | germinal center formation (GO:0002467) | 4.65873735 |
| 55 | positive regulation of type 2 immune response (GO:0002830) | 4.63613586 |
| 56 | regulation of tyrosine phosphorylation of STAT protein (GO:0042509) | 4.61730956 |
| 57 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.57817176 |
| 58 | positive regulation of cell killing (GO:0031343) | 4.54542668 |
| 59 | positive regulation of heat generation (GO:0031652) | 4.48847958 |
| 60 | regulation of vitamin metabolic process (GO:0030656) | 4.45313074 |
| 61 | positive regulation of JAK-STAT cascade (GO:0046427) | 4.42963054 |
| 62 | positive regulation of osteoclast differentiation (GO:0045672) | 4.42927613 |
| 63 | regulation of fever generation (GO:0031620) | 4.42014268 |
| 64 | negative regulation of interleukin-12 production (GO:0032695) | 4.40006116 |
| 65 | regulation of T cell cytokine production (GO:0002724) | 4.38692496 |
| 66 | osteoclast differentiation (GO:0030316) | 4.37522194 |
| 67 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.33110952 |
| 68 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.26527792 |
| 69 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.26527792 |
| 70 | T cell migration (GO:0072678) | 4.23313526 |
| 71 | regulation of macrophage chemotaxis (GO:0010758) | 4.20857643 |
| 72 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.19946063 |
| 73 | positive regulation of leukocyte mediated immunity (GO:0002705) | 4.19239445 |
| 74 | positive regulation of lymphocyte migration (GO:2000403) | 4.18636258 |
| 75 | negative regulation of cytokine production involved in immune response (GO:0002719) | 4.14288296 |
| 76 | cellular response to interleukin-15 (GO:0071350) | 4.10072406 |
| 77 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.07565618 |
| 78 | regulation of interleukin-17 production (GO:0032660) | 4.04318843 |
| 79 | positive regulation of T-helper 1 type immune response (GO:0002827) | 4.03322548 |
| 80 | positive regulation of T cell migration (GO:2000406) | 4.01390541 |
| 81 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.98398349 |
| 82 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.95711357 |
| 83 | response to interleukin-15 (GO:0070672) | 3.94588205 |
| 84 | T cell proliferation (GO:0042098) | 3.94235030 |
| 85 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.93519534 |
| 86 | regulation of growth of symbiont in host (GO:0044126) | 3.93519534 |
| 87 | negative regulation of growth of symbiont in host (GO:0044130) | 3.93519534 |
| 88 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.93519534 |
| 89 | regulation of monocyte differentiation (GO:0045655) | 3.91306484 |
| 90 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.91005377 |
| 91 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.90977241 |
| 92 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.88695107 |
| 93 | leukocyte aggregation (GO:0070486) | 3.86980892 |
| 94 | regulation of cell killing (GO:0031341) | 3.84766875 |
| 95 | regulation of lymphocyte migration (GO:2000401) | 3.83994955 |
| 96 | regulation of activated T cell proliferation (GO:0046006) | 3.81538798 |
| 97 | decidualization (GO:0046697) | 3.81099071 |
| 98 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.80549089 |
| 99 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.76621465 |
| 100 | negative T cell selection (GO:0043383) | 3.75204759 |
| 101 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.73796885 |
| 102 | positive regulation of production of molecular mediator of immune response (GO:0002702) | 3.70719643 |
| 103 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.70510484 |
| 104 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.69264340 |
| 105 | cellular response to nicotine (GO:0071316) | 3.68276726 |
| 106 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.66466934 |
| 107 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.61495341 |
| 108 | positive regulation of myeloid leukocyte differentiation (GO:0002763) | 3.60418333 |
| 109 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.59129565 |
| 110 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.58576687 |
| 111 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 3.57543544 |
| 112 | positive regulation of adaptive immune response (GO:0002821) | 3.56357133 |
| 113 | lymphocyte chemotaxis (GO:0048247) | 3.53563639 |
| 114 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.53134433 |
| 115 | regulation of prostaglandin secretion (GO:0032306) | 3.51823007 |
| 116 | response to peptidoglycan (GO:0032494) | 3.48456929 |
| 117 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 3.44762756 |
| 118 | granulocyte chemotaxis (GO:0071621) | 3.44073701 |
| 119 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.42790034 |
| 120 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.42790034 |
| 121 | regulation of gamma-delta T cell activation (GO:0046643) | 3.42759890 |
| 122 | negative regulation of interleukin-2 production (GO:0032703) | 3.42695003 |
| 123 | regulation of B cell apoptotic process (GO:0002902) | 3.42592987 |
| 124 | regulation of T cell migration (GO:2000404) | 3.42546737 |
| 125 | negative thymic T cell selection (GO:0045060) | 3.41907357 |
| 126 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.40724697 |
| 127 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.36597123 |
| 128 | regulation of T-helper 1 type immune response (GO:0002825) | 3.35253115 |
| 129 | positive regulation of organelle assembly (GO:1902117) | 3.33760032 |
| 130 | regulation of heat generation (GO:0031650) | 3.31254985 |
| 131 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.29311897 |
| 132 | granulocyte migration (GO:0097530) | 3.29177829 |
| 133 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.24080270 |
| 134 | lymphocyte migration (GO:0072676) | 3.22657848 |
| 135 | negative regulation of interleukin-17 production (GO:0032700) | 3.17410014 |
| 136 | positive regulation of macrophage differentiation (GO:0045651) | 3.15557552 |
| 137 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.14005283 |
| 138 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.13527982 |
| 139 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.03971945 |
| 140 | positive regulation of prostaglandin secretion (GO:0032308) | 3.03296757 |
| 141 | neutrophil chemotaxis (GO:0030593) | 3.02803359 |
| 142 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.97325247 |
| 143 | neutrophil migration (GO:1990266) | 2.94824965 |
| 144 | positive regulation of macrophage activation (GO:0043032) | 2.93306054 |
| 145 | positive regulation of leukocyte chemotaxis (GO:0002690) | 2.93300846 |
| 146 | regulation of histone phosphorylation (GO:0033127) | 2.87966900 |
| 147 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.80649481 |
| 148 | macrophage differentiation (GO:0030225) | 2.80239572 |
| 149 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.79307362 |
| 150 | cellular response to lipopolysaccharide (GO:0071222) | 2.78959024 |
| 151 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.77862422 |
| 152 | positive regulation of acute inflammatory response (GO:0002675) | 2.77815077 |
| 153 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.77555658 |
| 154 | neutrophil mediated immunity (GO:0002446) | 2.77366572 |
| 155 | positive regulation of myeloid cell differentiation (GO:0045639) | 2.74364911 |
| 156 | regulation of chemokine biosynthetic process (GO:0045073) | 2.71920497 |
| 157 | type I interferon signaling pathway (GO:0060337) | 2.71289184 |
| 158 | cellular response to type I interferon (GO:0071357) | 2.71289184 |
| 159 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.70931058 |
| 160 | necroptotic process (GO:0070266) | 2.70681617 |
| 161 | response to protozoan (GO:0001562) | 2.70276340 |
| 162 | positive regulation of macrophage cytokine production (GO:0060907) | 2.70084559 |
| 163 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.69948158 |
| 164 | positive regulation of granulocyte differentiation (GO:0030854) | 2.69754098 |
| 165 | response to type I interferon (GO:0034340) | 2.69202309 |
| 166 | cellular response to molecule of bacterial origin (GO:0071219) | 2.67124246 |
| 167 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.60581573 |
| 168 | positive regulation of B cell proliferation (GO:0030890) | 2.59005616 |
| 169 | T-helper 1 type immune response (GO:0042088) | 2.58773065 |
| 170 | regulation of granulocyte chemotaxis (GO:0071622) | 2.58321544 |
| 171 | negative regulation of monooxygenase activity (GO:0032769) | 2.57929127 |
| 172 | response to muramyl dipeptide (GO:0032495) | 2.57744848 |
| 173 | regulation of macrophage differentiation (GO:0045649) | 2.55524132 |
| 174 | DNA integration (GO:0015074) | 2.54819878 |
| 175 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.54665468 |
| 176 | positive regulation of leukocyte migration (GO:0002687) | 2.54377002 |
| 177 | myeloid leukocyte migration (GO:0097529) | 2.54317169 |
| 178 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.54043853 |
| 179 | regulation of hypersensitivity (GO:0002883) | 2.48690115 |
| 180 | regulation of necroptotic process (GO:0060544) | 2.47796211 |
| 181 | toll-like receptor 3 signaling pathway (GO:0034138) | 2.47262530 |
| 182 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.47195490 |
| 183 | TRIF-dependent toll-like receptor signaling pathway (GO:0035666) | 2.46359808 |
| 184 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 12.2476461 |
| 185 | regulation of isotype switching to IgG isotypes (GO:0048302) | 10.1731644 |
| 186 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 10.1265951 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 9.58844847 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.42172739 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.56346886 |
| 4 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 4.59325922 |
| 5 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.53952984 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.18298075 |
| 7 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.77014543 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.61194658 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.51244356 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.45814778 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.29750725 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.28618787 |
| 13 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.06760747 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.91012731 |
| 15 | * MYB_26560356_Chip-Seq_TH2_Human | 2.84546895 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.77633191 |
| 17 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.70845911 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.58252007 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.55696033 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.49321777 |
| 21 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.49026708 |
| 22 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.42836297 |
| 23 | MYB_26560356_Chip-Seq_TH1_Human | 2.39504791 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.13629394 |
| 25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.07437497 |
| 26 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 2.07411273 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.92952243 |
| 28 | MAF_26560356_Chip-Seq_TH2_Human | 1.90373543 |
| 29 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.87376622 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.85017184 |
| 31 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.76587232 |
| 32 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.75738933 |
| 33 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.69223297 |
| 34 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.65457873 |
| 35 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59350310 |
| 36 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.54702004 |
| 37 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.53592979 |
| 38 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.51940539 |
| 39 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.49847178 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.48178720 |
| 41 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.48041645 |
| 42 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.46847641 |
| 43 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.44207119 |
| 44 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.43431667 |
| 45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.40037044 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40010488 |
| 47 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.39153418 |
| 48 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.37079187 |
| 49 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36279342 |
| 50 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34408543 |
| 51 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33625589 |
| 52 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.33431893 |
| 53 | GATA3_26560356_Chip-Seq_TH2_Human | 1.32004352 |
| 54 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31221561 |
| 55 | GATA1_19941826_ChIP-Seq_K562_Human | 1.29557317 |
| 56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.28737344 |
| 57 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.25651728 |
| 58 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.25100199 |
| 59 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23547057 |
| 60 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.19361071 |
| 61 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15007578 |
| 62 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14087769 |
| 63 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.13916557 |
| 64 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.13117332 |
| 65 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.12893532 |
| 66 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.12606254 |
| 67 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.11308396 |
| 68 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.09941734 |
| 69 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.08513589 |
| 70 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.04873235 |
| 71 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.04490734 |
| 72 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.04060382 |
| 73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02699120 |
| 74 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02054129 |
| 75 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99005951 |
| 76 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.97837398 |
| 77 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.97015966 |
| 78 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.96902909 |
| 79 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.96302948 |
| 80 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96108585 |
| 81 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.96049386 |
| 82 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95110409 |
| 83 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94305173 |
| 84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93004438 |
| 85 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92587406 |
| 86 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.89055796 |
| 87 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.87442132 |
| 88 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.86759663 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.86392346 |
| 90 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.85364257 |
| 91 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.85102817 |
| 92 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.85077903 |
| 93 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85010046 |
| 94 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83909773 |
| 95 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.82020214 |
| 96 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81407618 |
| 97 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.80166955 |
| 98 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.80117758 |
| 99 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.79486827 |
| 100 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.78669834 |
| 101 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.77245068 |
| 102 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.76455347 |
| 103 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.75913372 |
| 104 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75428973 |
| 105 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.73912484 |
| 106 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.73850907 |
| 107 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.73689576 |
| 108 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72252282 |
| 109 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.70729283 |
| 110 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.70534994 |
| 111 | SPI1_23127762_ChIP-Seq_K562_Human | 0.70156429 |
| 112 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.70139665 |
| 113 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.69443950 |
| 114 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.66782526 |
| 115 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65967792 |
| 116 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.64937242 |
| 117 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.64246275 |
| 118 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.63689346 |
| 119 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.62940799 |
| 120 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.62738821 |
| 121 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.62030965 |
| 122 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.61771106 |
| 123 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.57458392 |
| 124 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.56771157 |
| 125 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.56457176 |
| 126 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.55303152 |
| 127 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.54185370 |
| 128 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.52915957 |
| 129 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.50059616 |
| 130 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.49540819 |
| 131 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.47573546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003300_gastrointestinal_ulcer | 6.86020174 |
| 2 | MP0001835_abnormal_antigen_presentation | 5.69472641 |
| 3 | MP0005671_abnormal_response_to | 5.66039955 |
| 4 | MP0001853_heart_inflammation | 3.97477482 |
| 5 | MP0004782_abnormal_surfactant_physiolog | 3.88406677 |
| 6 | MP0003436_decreased_susceptibility_to | 3.71039633 |
| 7 | MP0000604_amyloidosis | 3.58645377 |
| 8 | MP0000465_gastrointestinal_hemorrhage | 3.57326755 |
| 9 | MP0009840_abnormal_foam_cell | 3.53786643 |
| 10 | MP0003763_abnormal_thymus_physiology | 3.52057943 |
| 11 | MP0000685_abnormal_immune_system | 3.34381018 |
| 12 | MP0001958_emphysema | 3.24288030 |
| 13 | MP0005167_abnormal_blood-brain_barrier | 3.22734116 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 3.20959776 |
| 15 | MP0002405_respiratory_system_inflammati | 3.15936783 |
| 16 | MP0009785_altered_susceptibility_to | 2.88087922 |
| 17 | MP0006082_CNS_inflammation | 2.87740255 |
| 18 | MP0009278_abnormal_bone_marrow | 2.69462944 |
| 19 | MP0002877_abnormal_melanocyte_morpholog | 2.67500388 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.65827131 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.64579569 |
| 22 | MP0001800_abnormal_humoral_immune | 2.51252974 |
| 23 | MP0003303_peritoneal_inflammation | 2.35847414 |
| 24 | MP0000343_altered_response_to | 2.29704626 |
| 25 | MP0005025_abnormal_response_to | 2.15903964 |
| 26 | MP0001873_stomach_inflammation | 2.14810035 |
| 27 | MP0003866_abnormal_defecation | 2.13372557 |
| 28 | MP0002723_abnormal_immune_serum | 2.11525753 |
| 29 | MP0005387_immune_system_phenotype | 2.06849256 |
| 30 | MP0001790_abnormal_immune_system | 2.06849256 |
| 31 | MP0002398_abnormal_bone_marrow | 2.00097042 |
| 32 | MP0002420_abnormal_adaptive_immunity | 1.98323131 |
| 33 | MP0005058_abnormal_lysosome_morphology | 1.96771491 |
| 34 | MP0001819_abnormal_immune_cell | 1.95516090 |
| 35 | MP0003172_abnormal_lysosome_physiology | 1.94837768 |
| 36 | MP0003806_abnormal_nucleotide_metabolis | 1.93714843 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.84761369 |
| 38 | MP0005451_abnormal_body_composition | 1.84559456 |
| 39 | MP0004233_abnormal_muscle_weight | 1.77609212 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.74267106 |
| 41 | MP0003045_fibrosis | 1.72908540 |
| 42 | MP0002452_abnormal_antigen_presenting | 1.71434716 |
| 43 | MP0004510_myositis | 1.65885830 |
| 44 | MP0001501_abnormal_sleep_pattern | 1.63477903 |
| 45 | MP0000716_abnormal_immune_system | 1.62216933 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.61138375 |
| 47 | MP0000703_abnormal_thymus_morphology | 1.56860661 |
| 48 | MP0002722_abnormal_immune_system | 1.52463930 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.52169103 |
| 50 | MP0002006_tumorigenesis | 1.52149234 |
| 51 | MP0008004_abnormal_stomach_pH | 1.47020329 |
| 52 | MP0002419_abnormal_innate_immunity | 1.46130271 |
| 53 | MP0008057_abnormal_DNA_replication | 1.43258144 |
| 54 | MP0002139_abnormal_hepatobiliary_system | 1.35109822 |
| 55 | MP0002429_abnormal_blood_cell | 1.34507515 |
| 56 | MP0002396_abnormal_hematopoietic_system | 1.32825959 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.31763874 |
| 58 | MP0001881_abnormal_mammary_gland | 1.28054273 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 1.26046340 |
| 60 | MP0000371_diluted_coat_color | 1.24152440 |
| 61 | MP0002132_abnormal_respiratory_system | 1.22561283 |
| 62 | MP0003448_altered_tumor_morphology | 1.20652828 |
| 63 | MP0010307_abnormal_tumor_latency | 1.19278763 |
| 64 | MP0004947_skin_inflammation | 1.17192599 |
| 65 | MP0008260_abnormal_autophagy | 1.16202851 |
| 66 | MP0003724_increased_susceptibility_to | 1.12743300 |
| 67 | MP0001348_abnormal_lacrimal_gland | 1.12566825 |
| 68 | MP0010352_gastrointestinal_tract_polyps | 1.11415782 |
| 69 | MP0001849_ear_inflammation | 1.08715847 |
| 70 | MP0002837_dystrophic_cardiac_calcinosis | 1.06084780 |
| 71 | MP0003091_abnormal_cell_migration | 1.03820693 |
| 72 | MP0002138_abnormal_hepatobiliary_system | 1.02275779 |
| 73 | MP0004808_abnormal_hematopoietic_stem | 1.01429111 |
| 74 | MP0003195_calcinosis | 1.00676416 |
| 75 | MP0000920_abnormal_myelination | 0.99283693 |
| 76 | MP0009764_decreased_sensitivity_to | 0.98390062 |
| 77 | MP0002933_joint_inflammation | 0.95491364 |
| 78 | MP0005164_abnormal_response_to | 0.91301403 |
| 79 | MP0005165_increased_susceptibility_to | 0.82646949 |
| 80 | MP0008469_abnormal_protein_level | 0.82178349 |
| 81 | MP0003828_pulmonary_edema | 0.81266775 |
| 82 | MP0002254_reproductive_system_inflammat | 0.78778783 |
| 83 | MP0005464_abnormal_platelet_physiology | 0.78531697 |
| 84 | MP0000858_altered_metastatic_potential | 0.78434484 |
| 85 | MP0008874_decreased_physiological_sensi | 0.78268647 |
| 86 | MP0000569_abnormal_digit_pigmentation | 0.77584765 |
| 87 | MP0003690_abnormal_glial_cell | 0.77147987 |
| 88 | MP0002693_abnormal_pancreas_physiology | 0.76700918 |
| 89 | MP0005166_decreased_susceptibility_to | 0.76189939 |
| 90 | MP0003183_abnormal_peptide_metabolism | 0.76182145 |
| 91 | MP0002019_abnormal_tumor_incidence | 0.72011315 |
| 92 | MP0003646_muscle_fatigue | 0.70833760 |
| 93 | MP0000609_abnormal_liver_physiology | 0.68000767 |
| 94 | MP0002168_other_aberrant_phenotype | 0.65918826 |
| 95 | MP0003191_abnormal_cellular_cholesterol | 0.65582641 |
| 96 | MP0003329_amyloid_beta_deposits | 0.65446161 |
| 97 | MP0000627_abnormal_mammary_gland | 0.64807898 |
| 98 | MP0000490_abnormal_crypts_of | 0.61511110 |
| 99 | MP0005319_abnormal_enzyme/_coenzyme | 0.61123171 |
| 100 | MP0002332_abnormal_exercise_endurance | 0.60488504 |
| 101 | MP0001663_abnormal_digestive_system | 0.60206517 |
| 102 | MP0009763_increased_sensitivity_to | 0.60066483 |
| 103 | MP0000249_abnormal_blood_vessel | 0.57962682 |
| 104 | MP0009765_abnormal_xenobiotic_induced | 0.56395352 |
| 105 | MP0005390_skeleton_phenotype | 0.56080883 |
| 106 | MP0002075_abnormal_coat/hair_pigmentati | 0.55263983 |
| 107 | MP0001186_pigmentation_phenotype | 0.54547944 |
| 108 | MP0004742_abnormal_vestibular_system | 0.53140902 |
| 109 | MP0002998_abnormal_bone_remodeling | 0.53020652 |
| 110 | MP0004883_abnormal_blood_vessel | 0.52563579 |
| 111 | MP0001216_abnormal_epidermal_layer | 0.51172156 |
| 112 | MP0005310_abnormal_salivary_gland | 0.45896675 |
| 113 | MP0005076_abnormal_cell_differentiation | 0.45505956 |
| 114 | MP0003693_abnormal_embryo_hatching | 0.45401366 |
| 115 | MP0003453_abnormal_keratinocyte_physiol | 0.44765546 |
| 116 | MP0001727_abnormal_embryo_implantation | 0.44155025 |
| 117 | MP0008961_abnormal_basal_metabolism | 0.43524811 |
| 118 | MP0002136_abnormal_kidney_physiology | 0.42312418 |
| 119 | MP0003795_abnormal_bone_structure | 0.34242255 |
| 120 | MP0001851_eye_inflammation | 0.33388181 |
| 121 | MP0000598_abnormal_liver_morphology | 0.32418582 |
| 122 | MP0001485_abnormal_pinna_reflex | 0.32063313 |
| 123 | MP0002133_abnormal_respiratory_system | 0.30824727 |
| 124 | MP0005388_respiratory_system_phenotype | 0.30824727 |
| 125 | MP0005397_hematopoietic_system_phenotyp | 0.29964006 |
| 126 | MP0001545_abnormal_hematopoietic_system | 0.29964006 |
| 127 | MP0004197_abnormal_fetal_growth/weight/ | 0.29836165 |
| 128 | MP0003075_altered_response_to | 0.29194616 |
| 129 | MP0008569_lethality_at_weaning | 0.29123338 |
| 130 | MP0002083_premature_death | 0.24788250 |
| 131 | MP0005381_digestive/alimentary_phenotyp | 0.23338169 |
| 132 | MP0005647_abnormal_sex_gland | 0.22191203 |
| 133 | MP0002089_abnormal_postnatal_growth/wei | 0.22080667 |
| 134 | MP0001119_abnormal_female_reproductive | 0.21244359 |
| 135 | MP0004957_abnormal_blastocyst_morpholog | 0.20441585 |
| 136 | MP0004381_abnormal_hair_follicle | 0.19843088 |
| 137 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.19818142 |
| 138 | MP0005023_abnormal_wound_healing | 0.19676849 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 9.34485714 |
| 2 | T lymphocytopenia (HP:0005403) | 7.07216973 |
| 3 | Abnormality of T cell number (HP:0011839) | 7.06684516 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.67192200 |
| 5 | Nasal polyposis (HP:0100582) | 5.69927219 |
| 6 | Gastrointestinal infarctions (HP:0005244) | 5.63580231 |
| 7 | Increased IgM level (HP:0003496) | 5.59542956 |
| 8 | Increased density of long bones (HP:0006392) | 5.35394735 |
| 9 | Recurrent abscess formation (HP:0002722) | 5.28779169 |
| 10 | Abnormality of T cells (HP:0002843) | 5.24754386 |
| 11 | IgA deficiency (HP:0002720) | 5.20710608 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 4.83998251 |
| 13 | Abnormality of the nasal mucosa (HP:0000433) | 4.64597328 |
| 14 | Abnormality of macrophages (HP:0004311) | 4.61516666 |
| 15 | Persistence of primary teeth (HP:0006335) | 4.44682335 |
| 16 | IgG deficiency (HP:0004315) | 4.36553054 |
| 17 | Abnormality of glycolipid metabolism (HP:0010969) | 4.36410992 |
| 18 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.36410992 |
| 19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.36410992 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 4.30974036 |
| 21 | Thrombocytosis (HP:0001894) | 4.26187226 |
| 22 | Severe combined immunodeficiency (HP:0004430) | 4.19545251 |
| 23 | Eczematoid dermatitis (HP:0000976) | 4.18706150 |
| 24 | Recurrent viral infections (HP:0004429) | 4.15625433 |
| 25 | Recurrent bronchitis (HP:0002837) | 4.14334032 |
| 26 | Arterial thrombosis (HP:0004420) | 4.09788779 |
| 27 | Joint swelling (HP:0001386) | 4.04460357 |
| 28 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.98051670 |
| 29 | Recurrent fungal infections (HP:0002841) | 3.91660921 |
| 30 | Chronic otitis media (HP:0000389) | 3.77047251 |
| 31 | Amaurosis fugax (HP:0100576) | 3.75248334 |
| 32 | Abnormality of T cell physiology (HP:0011840) | 3.70296460 |
| 33 | Combined immunodeficiency (HP:0005387) | 3.62683126 |
| 34 | Chronic diarrhea (HP:0002028) | 3.42244914 |
| 35 | Myositis (HP:0100614) | 3.34112899 |
| 36 | Retrobulbar optic neuritis (HP:0100654) | 3.32095849 |
| 37 | Optic neuritis (HP:0100653) | 3.32095849 |
| 38 | Abnormality of B cell number (HP:0010975) | 3.27315973 |
| 39 | B lymphocytopenia (HP:0010976) | 3.27315973 |
| 40 | Mediastinal lymphadenopathy (HP:0100721) | 3.27078049 |
| 41 | Chest pain (HP:0100749) | 3.23379167 |
| 42 | Vasculitis (HP:0002633) | 3.21723007 |
| 43 | Thin bony cortex (HP:0002753) | 3.13082594 |
| 44 | Petechiae (HP:0000967) | 3.05474215 |
| 45 | Pulmonary infiltrates (HP:0002113) | 3.04051230 |
| 46 | Autoimmune thrombocytopenia (HP:0001973) | 3.02857602 |
| 47 | Hematochezia (HP:0002573) | 3.02411617 |
| 48 | Metaphyseal irregularity (HP:0003025) | 3.00773160 |
| 49 | Recurrent skin infections (HP:0001581) | 3.00518275 |
| 50 | Increased cerebral lipofuscin (HP:0011813) | 2.93237674 |
| 51 | Hypergammaglobulinemia (HP:0010702) | 2.91988490 |
| 52 | Loss of speech (HP:0002371) | 2.91793310 |
| 53 | Fatigue (HP:0012378) | 2.89434076 |
| 54 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.86149520 |
| 55 | Dysostosis multiplex (HP:0000943) | 2.85969377 |
| 56 | Panhypogammaglobulinemia (HP:0003139) | 2.84830115 |
| 57 | Leukocytosis (HP:0001974) | 2.79891318 |
| 58 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.77439035 |
| 59 | Orchitis (HP:0100796) | 2.77307361 |
| 60 | Anomalous pulmonary venous return (HP:0010772) | 2.68172135 |
| 61 | Gingival bleeding (HP:0000225) | 2.66233057 |
| 62 | Peritonitis (HP:0002586) | 2.63059557 |
| 63 | Myocardial infarction (HP:0001658) | 2.60500673 |
| 64 | Eosinophilia (HP:0001880) | 2.56298176 |
| 65 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.56080242 |
| 66 | Slow saccadic eye movements (HP:0000514) | 2.55283047 |
| 67 | Esophageal varix (HP:0002040) | 2.54225956 |
| 68 | Lymphoma (HP:0002665) | 2.52381627 |
| 69 | Abnormality of eosinophils (HP:0001879) | 2.51211408 |
| 70 | IgM deficiency (HP:0002850) | 2.50972812 |
| 71 | Lymphopenia (HP:0001888) | 2.48718803 |
| 72 | Aplastic anemia (HP:0001915) | 2.48025057 |
| 73 | Thrombophlebitis (HP:0004418) | 2.46564028 |
| 74 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.44807588 |
| 75 | Diplopia (HP:0000651) | 2.43958208 |
| 76 | Abnormality of binocular vision (HP:0011514) | 2.43958208 |
| 77 | Acute myeloid leukemia (HP:0004808) | 2.43584721 |
| 78 | Abnormality of the peritoneum (HP:0002585) | 2.42618426 |
| 79 | Cerebral hemorrhage (HP:0001342) | 2.37750611 |
| 80 | Enlarged epiphyses (HP:0010580) | 2.33984523 |
| 81 | Abnormality of the pulmonary veins (HP:0011718) | 2.33976306 |
| 82 | Cellulitis (HP:0100658) | 2.33131093 |
| 83 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.30908286 |
| 84 | Abnormality of oral frenula (HP:0000190) | 2.30339509 |
| 85 | Gangrene (HP:0100758) | 2.30121366 |
| 86 | Polycythemia (HP:0001901) | 2.30036455 |
| 87 | Urticaria (HP:0001025) | 2.28570153 |
| 88 | Hemoptysis (HP:0002105) | 2.28564059 |
| 89 | Autoimmune hemolytic anemia (HP:0001890) | 2.28375256 |
| 90 | Pulmonary embolism (HP:0002204) | 2.28182019 |
| 91 | Spontaneous abortion (HP:0005268) | 2.27383226 |
| 92 | Aplasia cutis congenita (HP:0001057) | 2.25210361 |
| 93 | Abnormal trabecular bone morphology (HP:0100671) | 2.24120055 |
| 94 | Hepatosplenomegaly (HP:0001433) | 2.23553756 |
| 95 | Upper motor neuron abnormality (HP:0002127) | 2.21845552 |
| 96 | Flat occiput (HP:0005469) | 2.18305754 |
| 97 | Gastrointestinal stroma tumor (HP:0100723) | 2.17498245 |
| 98 | Bronchitis (HP:0012387) | 2.16476934 |
| 99 | Abnormality of the prostate (HP:0008775) | 2.16175272 |
| 100 | Amyloidosis (HP:0011034) | 2.16055573 |
| 101 | Keratoconjunctivitis sicca (HP:0001097) | 2.15883022 |
| 102 | Porencephaly (HP:0002132) | 2.13830001 |
| 103 | Oral leukoplakia (HP:0002745) | 2.11441169 |
| 104 | Arthralgia (HP:0002829) | 2.09773060 |
| 105 | Granulocytopenia (HP:0001913) | 2.09384449 |
| 106 | Absent frontal sinuses (HP:0002688) | 2.09221603 |
| 107 | Neurofibrillary tangles (HP:0002185) | 2.08312066 |
| 108 | Gingivitis (HP:0000230) | 2.04932477 |
| 109 | Symptomatic seizures (HP:0011145) | 2.04832241 |
| 110 | Recurrent cutaneous fungal infections (HP:0011370) | 2.03730722 |
| 111 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.03730722 |
| 112 | Septate vagina (HP:0001153) | 2.03114914 |
| 113 | Somatic mutation (HP:0001428) | 2.00729272 |
| 114 | Delayed epiphyseal ossification (HP:0002663) | 1.99883219 |
| 115 | Spastic diplegia (HP:0001264) | 1.99360105 |
| 116 | Acute hepatic failure (HP:0006554) | 1.98076136 |
| 117 | Abnormality of the costochondral junction (HP:0000919) | 1.97497176 |
| 118 | Anorexia (HP:0002039) | 1.96940601 |
| 119 | Abnormal number of incisors (HP:0011064) | 1.96931642 |
| 120 | Bone pain (HP:0002653) | 1.95449382 |
| 121 | Rough bone trabeculation (HP:0100670) | 1.94563858 |
| 122 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.93840015 |
| 123 | Keratoconjunctivitis (HP:0001096) | 1.92910078 |
| 124 | Increased serum ferritin (HP:0003281) | 1.92369133 |
| 125 | Disinhibition (HP:0000734) | 1.91378980 |
| 126 | Submucous cleft hard palate (HP:0000176) | 1.91267178 |
| 127 | Cerebral ischemia (HP:0002637) | 1.90913596 |
| 128 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.90891745 |
| 129 | Thoracic kyphosis (HP:0002942) | 1.90816362 |
| 130 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.90504349 |
| 131 | Malnutrition (HP:0004395) | 1.89002832 |
| 132 | Hypophosphatemia (HP:0002148) | 1.88738877 |
| 133 | Protuberant abdomen (HP:0001538) | 1.88684410 |
| 134 | Diminished motivation (HP:0000745) | 1.87826492 |
| 135 | Spondylolisthesis (HP:0003302) | 1.86032995 |
| 136 | Neuronal loss in central nervous system (HP:0002529) | 1.85838150 |
| 137 | Chronic sinusitis (HP:0011109) | 1.85236185 |
| 138 | Cerebral inclusion bodies (HP:0100314) | 1.84401455 |
| 139 | Femoral bowing (HP:0002980) | 1.84242645 |
| 140 | Pathologic fracture (HP:0002756) | 1.83889763 |
| 141 | Hepatitis (HP:0012115) | 1.82808875 |
| 142 | Acrocyanosis (HP:0001063) | 1.82485700 |
| 143 | Restrictive lung disease (HP:0002091) | 1.81270765 |
| 144 | Obstructive lung disease (HP:0006536) | 1.81265111 |
| 145 | Chronic obstructive pulmonary disease (HP:0006510) | 1.81265111 |
| 146 | Meningitis (HP:0001287) | 1.80908026 |
| 147 | Increased CSF protein (HP:0002922) | 1.80673305 |
| 148 | Colitis (HP:0002583) | 1.80603703 |
| 149 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.80241098 |
| 150 | Portal hypertension (HP:0001409) | 1.77457992 |
| 151 | Emphysema (HP:0002097) | 1.77189436 |
| 152 | Impaired platelet aggregation (HP:0003540) | 1.77183728 |
| 153 | Abnormal platelet function (HP:0011869) | 1.77183728 |
| 154 | Encephalitis (HP:0002383) | 1.77008075 |
| 155 | Premature loss of primary teeth (HP:0006323) | 1.74250402 |
| 156 | Thoracolumbar scoliosis (HP:0002944) | 1.73049535 |
| 157 | Exertional dyspnea (HP:0002875) | 1.72927897 |
| 158 | Peripheral hypomyelination (HP:0007182) | 1.72683785 |
| 159 | Pustule (HP:0200039) | 1.72291435 |
| 160 | Cutis marmorata (HP:0000965) | 1.71534404 |
| 161 | Periodontitis (HP:0000704) | 1.71065762 |
| 162 | Increased IgE level (HP:0003212) | 1.69741971 |
| 163 | Nausea (HP:0002018) | 1.69555697 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 9.24207361 |
| 2 | TXK | 7.36073359 |
| 3 | MAP4K1 | 6.36520299 |
| 4 | JAK3 | 3.95654888 |
| 5 | ITK | 3.81874235 |
| 6 | ZAP70 | 3.61560420 |
| 7 | MAP3K14 | 3.40460567 |
| 8 | PRPF4B | 2.89992155 |
| 9 | PIM2 | 2.89662902 |
| 10 | RIPK4 | 2.74661847 |
| 11 | MATK | 2.51283347 |
| 12 | TTN | 2.44104088 |
| 13 | CSK | 2.20280645 |
| 14 | TEC | 2.15187880 |
| 15 | CAMK1D | 2.00306980 |
| 16 | IKBKB | 1.98300906 |
| 17 | MAP3K11 | 1.93009796 |
| 18 | CAMKK2 | 1.91693201 |
| 19 | CHUK | 1.87489810 |
| 20 | DDR2 | 1.85758041 |
| 21 | FGFR4 | 1.82909670 |
| 22 | TAOK1 | 1.74975926 |
| 23 | TYK2 | 1.69760376 |
| 24 | TBK1 | 1.61449241 |
| 25 | LCK | 1.59226946 |
| 26 | IKBKE | 1.57138833 |
| 27 | NME1 | 1.53395098 |
| 28 | TAOK2 | 1.50858439 |
| 29 | CAMK1G | 1.47728363 |
| 30 | NME2 | 1.41677673 |
| 31 | SYK | 1.32123835 |
| 32 | BTK | 1.30876768 |
| 33 | HCK | 1.29361815 |
| 34 | JAK1 | 1.28590249 |
| 35 | MAP3K7 | 1.23013642 |
| 36 | RAF1 | 1.20016544 |
| 37 | CDC42BPA | 1.19640787 |
| 38 | PIM1 | 1.16841980 |
| 39 | EPHA3 | 1.15322967 |
| 40 | STK10 | 1.11396396 |
| 41 | FGFR3 | 1.07506076 |
| 42 | FES | 1.06047967 |
| 43 | TESK2 | 1.05060622 |
| 44 | ALK | 1.03773647 |
| 45 | JAK2 | 1.02562043 |
| 46 | MAP2K3 | 1.00026135 |
| 47 | ICK | 0.99778557 |
| 48 | MAP3K13 | 0.98323356 |
| 49 | FGFR1 | 0.94598274 |
| 50 | TSSK6 | 0.94355249 |
| 51 | BMPR2 | 0.87608029 |
| 52 | MAP3K3 | 0.86348256 |
| 53 | PRKCQ | 0.83491801 |
| 54 | EEF2K | 0.82693878 |
| 55 | EPHB1 | 0.82348527 |
| 56 | STK24 | 0.82022173 |
| 57 | MST4 | 0.81502706 |
| 58 | PAK2 | 0.79316788 |
| 59 | TRIB3 | 0.79087168 |
| 60 | LYN | 0.78886612 |
| 61 | IRAK4 | 0.77918269 |
| 62 | RPS6KA4 | 0.75511532 |
| 63 | MST1R | 0.74809481 |
| 64 | MAP3K8 | 0.74738665 |
| 65 | LRRK2 | 0.74324126 |
| 66 | PRKCH | 0.73448789 |
| 67 | NTRK2 | 0.70673926 |
| 68 | MOS | 0.69673942 |
| 69 | EIF2AK1 | 0.68270718 |
| 70 | RPS6KA2 | 0.67417281 |
| 71 | TLK1 | 0.66639111 |
| 72 | RPS6KA5 | 0.65214783 |
| 73 | GRK7 | 0.64195979 |
| 74 | RPS6KC1 | 0.63139225 |
| 75 | RPS6KL1 | 0.63139225 |
| 76 | LIMK1 | 0.62636315 |
| 77 | KSR2 | 0.61798391 |
| 78 | GSK3A | 0.59819842 |
| 79 | IRAK1 | 0.56492623 |
| 80 | TYRO3 | 0.55336889 |
| 81 | MAPK11 | 0.52689280 |
| 82 | STK39 | 0.52149438 |
| 83 | RPS6KA6 | 0.52071242 |
| 84 | ROCK2 | 0.52047530 |
| 85 | MAP3K6 | 0.50309929 |
| 86 | TAOK3 | 0.50146873 |
| 87 | MARK3 | 0.48454457 |
| 88 | INSR | 0.48357016 |
| 89 | EGFR | 0.47936763 |
| 90 | SIK2 | 0.47932278 |
| 91 | CAMKK1 | 0.45136123 |
| 92 | CDK12 | 0.44990952 |
| 93 | BMX | 0.43063266 |
| 94 | WNK1 | 0.42911698 |
| 95 | SRPK1 | 0.42105245 |
| 96 | MAPK4 | 0.41640619 |
| 97 | PDPK1 | 0.40768970 |
| 98 | MAP3K1 | 0.39825704 |
| 99 | NEK9 | 0.39718153 |
| 100 | KIT | 0.38809898 |
| 101 | MAP3K5 | 0.38765108 |
| 102 | ABL2 | 0.38347975 |
| 103 | KDR | 0.37162603 |
| 104 | IGF1R | 0.37111460 |
| 105 | WNK4 | 0.36187905 |
| 106 | ARAF | 0.35547052 |
| 107 | FLT3 | 0.35545706 |
| 108 | PKN1 | 0.34933089 |
| 109 | PKN2 | 0.34290661 |
| 110 | PAK4 | 0.34018113 |
| 111 | TRPM7 | 0.32793978 |
| 112 | RPS6KA1 | 0.32626267 |
| 113 | PDK1 | 0.30425911 |
| 114 | CDK4 | 0.29564401 |
| 115 | ERN1 | 0.27522706 |
| 116 | RPS6KB2 | 0.26890138 |
| 117 | SCYL2 | 0.26792665 |
| 118 | CDK6 | 0.24741073 |
| 119 | PASK | 0.24252728 |
| 120 | MKNK1 | 0.24024839 |
| 121 | MAP3K10 | 0.23581998 |
| 122 | PDGFRB | 0.23577685 |
| 123 | CHEK1 | 0.22290427 |
| 124 | PDGFRA | 0.21530667 |
| 125 | CDK9 | 0.20906591 |
| 126 | ABL1 | 0.20772267 |
| 127 | BLK | 0.19622346 |
| 128 | BRD4 | 0.19256009 |
| 129 | FYN | 0.19033810 |
| 130 | NLK | 0.18802024 |
| 131 | MAPKAPK2 | 0.18283479 |
| 132 | GRK6 | 0.16817748 |
| 133 | MELK | 0.16458196 |
| 134 | FGR | 0.15327968 |
| 135 | CLK1 | 0.15200986 |
| 136 | KSR1 | 0.14930583 |
| 137 | CSNK2A2 | 0.14100419 |
| 138 | MAPK3 | 0.13287324 |
| 139 | PRKCB | 0.12932462 |
| 140 | ERBB4 | 0.12473377 |
| 141 | TGFBR2 | 0.12173529 |
| 142 | AURKB | 0.10707386 |
| 143 | PRKACG | 0.10583413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 6.97786329 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 6.21245917 |
| 3 | Asthma_Homo sapiens_hsa05310 | 5.54670885 |
| 4 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 5.44897616 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.98753059 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.93626368 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.92741460 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.51095919 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.44112044 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.32941596 |
| 11 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 2.13615357 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.05898317 |
| 13 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.98868467 |
| 14 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.87552659 |
| 15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.86612493 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.81418532 |
| 17 | Bladder cancer_Homo sapiens_hsa05219 | 1.73162704 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.67776999 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.56853087 |
| 20 | Lysosome_Homo sapiens_hsa04142 | 1.53327541 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.50587567 |
| 22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.50057308 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.40469179 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.36958532 |
| 25 | Phagosome_Homo sapiens_hsa04145 | 1.34409632 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.26378629 |
| 27 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.25808329 |
| 28 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.24183068 |
| 29 | Salmonella infection_Homo sapiens_hsa05132 | 1.13731968 |
| 30 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.10338016 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.09248519 |
| 32 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.04512377 |
| 33 | Malaria_Homo sapiens_hsa05144 | 0.99563034 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.98046836 |
| 35 | Viral myocarditis_Homo sapiens_hsa05416 | 0.96820615 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.92708828 |
| 37 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.92296310 |
| 38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.88474475 |
| 39 | Amoebiasis_Homo sapiens_hsa05146 | 0.88327005 |
| 40 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.87718842 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 0.86348258 |
| 42 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.85732497 |
| 43 | HTLV-I infection_Homo sapiens_hsa05166 | 0.85083920 |
| 44 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.84568746 |
| 45 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.84005487 |
| 46 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.80794058 |
| 47 | Legionellosis_Homo sapiens_hsa05134 | 0.79129642 |
| 48 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.74548570 |
| 49 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71904419 |
| 50 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.70974035 |
| 51 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69113511 |
| 52 | Pertussis_Homo sapiens_hsa05133 | 0.68919449 |
| 53 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63909005 |
| 54 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62889940 |
| 55 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.61419506 |
| 56 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56541621 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 0.56012028 |
| 58 | Influenza A_Homo sapiens_hsa05164 | 0.54622513 |
| 59 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.53856820 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52011405 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50872291 |
| 62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.49399825 |
| 63 | Tuberculosis_Homo sapiens_hsa05152 | 0.49197451 |
| 64 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.48462732 |
| 65 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47616034 |
| 66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46055396 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45743250 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45309687 |
| 69 | Shigellosis_Homo sapiens_hsa05131 | 0.43833507 |
| 70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.43634258 |
| 71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43154773 |
| 72 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.41856195 |
| 73 | Mineral absorption_Homo sapiens_hsa04978 | 0.40668968 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39508845 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39044949 |
| 76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35768952 |
| 77 | Proteasome_Homo sapiens_hsa03050 | 0.31606542 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29017208 |
| 79 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.28434315 |
| 80 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.25437123 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.24539287 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.23894221 |
| 83 | Ribosome_Homo sapiens_hsa03010 | 0.23829492 |
| 84 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.23739325 |
| 85 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.23398298 |
| 86 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.23078522 |
| 87 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.22878809 |
| 88 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.21758871 |
| 89 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.20079922 |
| 90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.19928357 |
| 91 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.16627002 |
| 92 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.13995513 |
| 93 | RNA transport_Homo sapiens_hsa03013 | 0.11319829 |
| 94 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.10808699 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.10754684 |
| 96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.09912809 |
| 97 | Spliceosome_Homo sapiens_hsa03040 | 0.09331324 |
| 98 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.08619791 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.08195972 |
| 100 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.06767192 |
| 101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.05393970 |
| 102 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.04536373 |
| 103 | Platelet activation_Homo sapiens_hsa04611 | 0.03715644 |
| 104 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.01935800 |
| 105 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.01748183 |
| 106 | Colorectal cancer_Homo sapiens_hsa05210 | 0.01618077 |
| 107 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | -0.1240969 |
| 108 | mRNA surveillance pathway_Homo sapiens_hsa03015 | -0.1203294 |
| 109 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | -0.1145725 |
| 110 | ErbB signaling pathway_Homo sapiens_hsa04012 | -0.1050599 |
| 111 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | -0.1027563 |
| 112 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | -0.0987403 |
| 113 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | -0.0760279 |
| 114 | RNA degradation_Homo sapiens_hsa03018 | -0.0755929 |
| 115 | RNA polymerase_Homo sapiens_hsa03020 | -0.0727405 |
| 116 | Cocaine addiction_Homo sapiens_hsa05030 | -0.0700193 |
| 117 | Proteoglycans in cancer_Homo sapiens_hsa05205 | -0.0689845 |
| 118 | Thyroid cancer_Homo sapiens_hsa05216 | -0.0675829 |
| 119 | p53 signaling pathway_Homo sapiens_hsa04115 | -0.0511434 |
| 120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0490135 |
| 121 | Prion diseases_Homo sapiens_hsa05020 | -0.0453493 |
| 122 | Alcoholism_Homo sapiens_hsa05034 | -0.0201857 |
| 123 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | -0.0097314 |
| 124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | -0.0089574 |
| 125 | Insulin resistance_Homo sapiens_hsa04931 | -0.0027472 |
| 126 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0008089 |

